| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Product name | Nicergoline |
| Cas number | 27848-84-6 |
| Appearance | White powder |
| MF | C24H26BrN3O3 |
| MW | 484.38554 |
Nicergoline is a semi-synthetic ergot derivative with alpha-receptor blocking and vasodilator effects. It can enhance the metabolism of brain cell energy, increase the utilization of oxygen and glucose, promote the conversion of neurotransmitter dopamine and enhance nerve conduction, strengthen brain protein biosynthesis, and improve brain function. Rapid absorption after oral administration, absolute bioavailability is less than 5%.
Nicergoline is an ergot derivative used to treat senile dementia and other disorders with vascular origins. It has been found to increase mental agility and enhance clarity and perception. It decreases vascular resistance and increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells. It has similar vasoactive properties in other areas of the body, particularly the lungs.It is used for vascular disorders such as cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.
1. Nicergoline is an ergot derivative used to treat senile dementia and other disorders with vascular origins.
2. It has been found to increase mental agility and enhance clarity and perception.
3. It decreases vascular resistanceand increases arterial blood flow in the brain, improving the utilization of oxygen and glucose by brain cells.
4. It has similar vasoactive properties in other areas of the body, particularly the lungs.
5. It is used for vascular disorders such as cerebral thrombosis and atherosclerosis, arterial blockages in the limbs, Raynaud's disease, vascular migraines, and retinopathy.
6. Nicergoline has been registered in over fifty countries and has been used for more than three decades for the treatment of cognitive, affective, and behavioral disorders of older people.
){kind=link}